NonInvasive Technologies, a Elkridge, Maryland based company, has a market ready technology for isolating millions of living somatic cells and gastrointestinal stem cells from a small pellet of fecal matter. The isolated cells can be used in the pharmaceutical sector for drug discovery, in the clinical diagnostics field for early detection and monitoring of chronic diseases (genomics, proteomics, etc.), and in the life sciences for downstream molecular genetics and other studies. The company is developing noninvasive tests for colorectal cancer screening and inflammatory bowel disease monitoring. The company has a portfolio of several domestic and international patents and several pending.
